Bacitracin Ophthalmic Ointment
Category: Anti-Infective, Ophthalmology
FDA status: Current · Last FDA update: Jun 1, 2026 · First posted: Mar 3, 2025 (in shortage 1 year 6 months) · 1 manufacturers, 1 listed presentations
As of Jun 1, 2026, the FDA lists Bacitracin Ophthalmic Ointment as currently in shortage. Of 1 manufacturer presentations, 1 Unavailable.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35) NDC 0574-4022-35 |
Padagis US LLC | Unavailable | Shortage is estimated for 24 months |
Related medications in shortage
Other Anti-Infective, Ophthalmology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Bacitracin Ophthalmic Ointment (FDA data as of Jun 1, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Bacitracin Ophthalmic Ointment. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/bacitracin-ophthalmic-ointment.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).